We are live on !
Find out more
Dmitry Balyasny Balyasny Asset Management
AUM
$80.2B
Turnover
42.78%
1-Year Est. Return
51.53%
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
This Fund
S&P 500
This Quarter Est. Return
+19.41%
1 Year Est. Return
+51.53%
3 Year Est. Return
+149.76%
5 Year Est. Return
+199.38%
10 Year Est. Return
+875.18%
AUM
$80.2B
AUM Growth
+$3.12B
(+4%)
Cap. Flow
-$3.01B
Cap. Flow % of AUM
Cap. Flow %
-3.76%
Top 10 Holdings %
Top 10 Hldgs %
13.57%
Holding
3,665
New
834
Increased
989
Reduced
995
Closed
734
Avg Time Held
Equity + Options
1.1
years
Top 10 Avg Time Held
Equity + Options
0.8
years
Top 20 Avg Time Held
Equity + Options
0.8
years
Avg Time Held Equity only
0.9
years
Top 10 Avg Time Held Equity only
0.4
years
Top 20 Avg Time Held Equity only
0.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SpaceX
SPCX
|
+$577M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$538M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$517M |
| 4 |
Texas Instruments
TXN
|
+$413M |
| 5 |
Roku
ROKU
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hologic
HOLX
|
+$357M |
| 2 |
Meta Platforms (Facebook)
META
|
+$326M |
| 3 |
Johnson Controls International
JCI
|
+$303M |
| 4 |
Applied Materials
AMAT
|
+$285M |
| 5 |
Coterra Energy
CTRA
|
+$285M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 36.95% |
| 2 | Technology | 12.69% |
| 3 | Industrials | 9.95% |
| 4 | Consumer Discretionary | 8.03% |
| 5 | Healthcare | 7.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1976
CALL
Redwire
RDW
$2.1B
| $1.34M | ﹤0.01% |
+109,900
| New | +$1.45M |
2026 Q2
0 quarters
|
|
1977
PUT
Estee Lauder
EL
$39.6B
| $1.34M | ﹤0.01% |
17,000
-279,200
| -94% | -$22.6M |
2024 Q1
9 quarters
|
|
1978
Yext
YEXT
$712M
| $1.34M | ﹤0.01% |
+287,296
| New | +$1.12M |
2026 Q2
0 quarters
|
|
1979
Leidos
LDOS
$17.9B
| $1.34M | ﹤0.01% |
13,015
+3,703
| +40% | +$492K |
2023 Q3
11 quarters
|
|
1980
EagleRock Land
EROK
$522M
| $1.34M | ﹤0.01% |
+62,912
| New | +$1.36M |
2026 Q2
0 quarters
|
|
1981
NYLIM Merger Arbitrage ETF
MNA
$262M
| $1.33M | ﹤0.01% |
36,585
+3,840
| +12% | +$140K |
2026 Q1
1 quarter
|
|
1982
PUT
Abivax
ABVX
$7.58B
| $1.33M | ﹤0.01% |
+10,000
| New | +$1.13M |
2026 Q2
0 quarters
|
|
1983
PUT
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.11B
| $1.33M | ﹤0.01% |
+19,400
| New | +$1.3M |
2026 Q2
0 quarters
|
|
1984
APA Corp
APA
$18.5B
| $1.33M | ﹤0.01% |
40,864
+15,098
| +59% | +$567K |
2022 Q3
15 quarters
|
|
1985
CALL
iShares MSCI Germany ETF
EWG
$1.53B
| $1.32M | ﹤0.01% |
+31,900
| New | +$1.34M |
2026 Q2
0 quarters
|
|
1986
Whitehawk Therapeutics
WHWK
$185M
| $1.32M | ﹤0.01% |
288,117
-262,324
| -48% | -$1.09M |
2026 Q1
1 quarter
|
|
1987
ONE Gas
OGS
$4.94B
| $1.32M | ﹤0.01% |
+17,118
| New | +$1.42M |
2026 Q2
0 quarters
|
|
1988
PUT
Li Auto
LI
$10.8B
| $1.32M | ﹤0.01% |
112,300
| – | – |
2025 Q1
5 quarters
|
|
1989
TriMas Corp
TRS
$1.37B
| $1.32M | ﹤0.01% |
29,222
-39,769
| -58% | -$1.58M |
2025 Q2
4 quarters
|
|
1990
NioCorp Developments
NB
$487M
| $1.31M | ﹤0.01% |
272,754
+181,156
| +198% | +$992K |
2025 Q3
3 quarters
|
|
1991
Banco de Chile
BCH
$18.5B
| $1.31M | ﹤0.01% |
+32,936
| New | +$1.25M |
2026 Q2
0 quarters
|
|
1992
Sprout Social
SPT
$730M
| $1.3M | ﹤0.01% |
+172,692
| New | +$1.12M |
2026 Q2
0 quarters
|
|
1993
PUT
UBS Group
UBS
$145B
| $1.3M | ﹤0.01% |
26,300
+10,400
| +65% | +$474K |
2025 Q1
5 quarters
|
|
1994
Carrier Global
CARR
$43.9B
| $1.3M | ﹤0.01% |
17,711
+5,984
| +51% | +$391K |
2025 Q3
3 quarters
|
|
1995
Recursion Pharmaceuticals
RXRX
$2.41B
| $1.3M | ﹤0.01% |
353,661
+186,613
| +112% | +$621K |
2025 Q3
3 quarters
|
|
1996
CALL
BellRing Brands
BRBR
$1.07B
| $1.29M | ﹤0.01% |
+100,000
| New | +$1.21M |
2026 Q2
0 quarters
|
|
1997
Firefly Aerospace
FLY
$3B
| $1.29M | ﹤0.01% |
+44,007
| New | +$1.65M |
2026 Q2
0 quarters
|
|
1998
HP
HPQ
$26B
| $1.29M | ﹤0.01% |
58,923
+45,221
| +330% | +$1M |
2025 Q1
5 quarters
|
|
1999
PUT
Vertex Pharmaceuticals
VRTX
$142B
| $1.29M | ﹤0.01% |
2,600
-3,700
| -59% | -$1.64M |
2025 Q4
2 quarters
|
|
2000
Taysha Gene Therapies
TSHA
$1.35B
| $1.29M | ﹤0.01% |
189,332
+106,313
| +128% | +$629K |
2025 Q4
2 quarters
|
|
Similar funds
Dmitry Balyasny's Q2 2026 Portfolio in Review
As of Q2 2026, Dmitry Balyasny held 3,665 positions worth $80.2B, up 4% from $77.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Dmitry Balyasny withdrew a net $3.01B in Q2 2026, closing 734 positions and reducing 995 holdings. Its most notable exit was Hologic, an estimated $357M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 37% of assets, down from 39% a quarter earlier, followed by Technology and Industrials.
Against the trend, Dmitry Balyasny opened a new position in SpaceX worth $581M.
- Dmitry Balyasny's largest Q2 2026 buy was SpaceX: 3,397,642 shares worth $581M.
- Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $538M increase.
- Dmitry Balyasny's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $326M.
- Dmitry Balyasny fully exited Hologic in Q2 2026, selling an estimated $357M.
- Dmitry Balyasny's ten largest holdings make up 14% of its $80.2B portfolio in Q2 2026.
- Dmitry Balyasny opened 834 new positions and closed 734 in Q2 2026.
- Dmitry Balyasny's portfolio value rose 4% quarter-over-quarter to $80.2B.
Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.